Cat Vaccination Antibody Titer Testing / FPV (Cat)

Pathogen / Biology

The feline panleukopenia virus (FPV) is a small, nonenveloped DNA virus belonging to the Parvoviridae family and is the causative agent of feline panleukopenia. FPV is exceptionally stable in the environment and endemic in many cat populations. Vaccination against FPV is considered a core vaccination worldwide, as the disease is severe and often fatal, particularly in kittens.

Transmission / Epidemiology

Transmission occurs primarily via the fecal-oral route, either directly from animal to animal or indirectly through a contaminated environment; due to the virus’s high persistence, indirect transmission is highly likely. Maternal antibodies protect puppies during the first weeks of life, but they can also block the immune response to vaccination and vary in duration from one individual to another. This underscores the importance of reliable, verifiable vaccine protection at both the individual animal and population levels.

Course & Symptoms

Panleukopenia presents as a severe, febrile systemic disease characterized by vomiting, diarrhea, dehydration, and marked leukopenia; in pregnant animals and puppies, severe disease progression and high mortality are possible. Since effective vaccines are available, ensuring adequate protection is the primary focus of preventive vaccination management.

Diagnostic Relevance

For FPV, there is a strong correlation between a detectable antibody titer and protection against the disease: A seropositive adult cat is generally considered protected against FPV and does not require routine booster vaccinations. Determining FPV antibody status is therefore useful for individually assessing the need for revaccination, verifying successful primary immunization, or, in young animals, narrowing down the appropriate vaccination timing after maternal antibodies have waned. For calicivirus and herpesvirus, this correlation is significantly weaker. The antibody titer is a measure of vaccination or immune status and does not indicate an acute infection.

Rapid Test Component

The Fassisi® Feline ParvoCheck detects FPV antibodies in serum, plasma, or whole blood, thereby supporting the assessment of vaccine protection and the decision regarding a booster vaccination. It is specifically designed to measure antibody or vaccination titers and is not intended for the acute detection of antigens in cases of suspected panleukopenia.

References can be found here.